Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Atai Life Sciences N.V. (ATAI)
Atai Life Sciences N.V. (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 297,158
  • Shares Outstanding, K 166,010
  • Annual Sales, $ 230 K
  • Annual Income, $ -152,390 K
  • 60-Month Beta 0.68
  • Price/Sales 1,332.35
  • Price/Cash Flow N/A
  • Price/Book 1.31
Trade ATAI with:

Options Overview Details

View History
  • Implied Volatility 143.35% ( +4.92%)
  • Historical Volatility 46.42%
  • IV Percentile 75%
  • IV Rank 28.27%
  • IV High 458.62% on 11/10/22
  • IV Low 19.11% on 06/15/22
  • Put/Call Vol Ratio 7.14
  • Today's Volume 114
  • Volume Avg (30-Day) 381
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 13,041
  • Open Int (30-Day) 13,059

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.21
  • Number of Estimates 3
  • High Estimate -0.20
  • Low Estimate -0.21
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6900 +3.55%
on 06/02/23
2.0750 -15.66%
on 05/15/23
-0.2100 (-10.71%)
since 05/09/23
3-Month
1.1400 +53.51%
on 03/15/23
2.2500 -22.22%
on 04/21/23
+0.3750 (+27.27%)
since 03/09/23
52-Week
1.1400 +53.51%
on 03/15/23
4.9600 -64.72%
on 08/26/22
-1.6200 (-48.07%)
since 06/09/22

Most Recent Stories

More News
After Falling 60% in 1 Year, Is Atai Life Sciences Stock Still a Buy?

Atai's stock is hurting, but its pipeline is still packed with promising programs.

CMPS : 7.84 (-2.73%)
ATAI : 1.7500 (-2.23%)
Why Shares of Atai Life Sciences Rose Friday

The company's co-founder and chairman increased his position and explained why.

ATAI : 1.7500 (-2.23%)
Why Atai Life Sciences Stock Stormed Higher This Week

The biotech's strong financial position may be attracting bargain buyers right now.

ATAI : 1.7500 (-2.23%)
ATI Physical Therapy, Inc. (ATIP) Reports Q4 Loss, Misses Revenue Estimates

ATI Physical Therapy, Inc. (ATIP) delivered earnings and revenue surprises of 0% and 1.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

ATIP : 0.1792 (+8.08%)
ATAI : 1.7500 (-2.23%)
RadNet (RDNT) Misses Q4 Earnings Estimates

RadNet (RDNT) delivered earnings and revenue surprises of -42.11% and 11.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

RDNT : 32.10 (+1.39%)
ATAI : 1.7500 (-2.23%)
Addus HomeCare (ADUS) Q4 Earnings and Revenues Beat Estimates

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 14.43% and 0.18%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ADUS : 92.48 (-1.95%)
ATAI : 1.7500 (-2.23%)
Wall Street Thinks These 2 Penny Stocks Could Go Parabolic

Wall Street is bullish on these two beaten-down healthcare stocks.

ATAI : 1.7500 (-2.23%)
SRNE : 0.3073 (-20.26%)
Down -34.59% in 4 Weeks, Here's Why You Should You Buy the Dip in atai Life Sciences N.V. (ATAI)

atai Life Sciences N.V. (ATAI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings...

ATAI : 1.7500 (-2.23%)
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry

EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END

CYBN.NE : 0.300 (-7.69%)
MMED.NE : 4.930 (-2.76%)
LOBEF : 0.0217 (-3.56%)
LOBE.CN : 0.030 (unch)
ATAI : 1.7500 (-2.23%)
CMPS : 7.84 (-2.73%)
CYBN : 0.2419 (+2.94%)
MNMD : 3.66 (-3.17%)
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry

/PRNewswire/ -- Even during the recent global supply chain problems, certain markets have continued to show growth. The psychedelic drugs markets is one of...

LOBE.CN : 0.030 (unch)
LOBEF : 0.0217 (-3.56%)
ATAI : 1.7500 (-2.23%)
CMPS : 7.84 (-2.73%)
CYBN : 0.2419 (+2.94%)
MNMD : 3.66 (-3.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.

See More

Key Turning Points

3rd Resistance Point 1.8953
2nd Resistance Point 1.8623
1st Resistance Point 1.8061
Last Price 1.7500
1st Support Level 1.7169
2nd Support Level 1.6839
3rd Support Level 1.6277

See More

52-Week High 4.9600
Fibonacci 61.8% 3.5008
Fibonacci 50% 3.0500
Fibonacci 38.2% 2.5992
Last Price 1.7500
52-Week Low 1.1400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar